Oral oncologyHumansMaleFemaleMiddle AgedNeoadjuvant Therapy
Response-adapted surgery after neoadjuvant immunochemotherapy in oral squamous cell carcinoma.
Qigen Fang, Junhui Yuan, Xu Zhang, Tao Huang, Lanwei Guo
Published: 202510.1016/j.oraloncology.2025.107769
Abstract
OBJECTIVE: The standard treatment for locally advanced oral squamous cell carcinoma (OSCC) involves radical surgery followed by adjuvant therapy, often resulting in significant functional impairment. Neoadjuvant immunochemotherapy (NICT) has emerged…
Preview only. Read the full abstract at the source